本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cellect Biotechnology Ltd.

13.17
0.0000
成交量:- -
成交额:- -
市值:1,291.23万
市盈率:-2.56
高:13.17
开:13.17
低:13.17
收:13.17
52周最高:35.52
52周最低:6.88
股本:98.04万
流通股本:94.29万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.1505
每股收益(LYR):-6.1107
净资产收益率:-120.42%
总资产收益率:-47.79%
市净率:8.34
市盈率(LYR):-2.16

数据加载中...

2021/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/04

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/22

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/03

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/17

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]